Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1725

1.

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.

Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.

Lancet. 2019 Jul 27;394(10195):303-313. doi: 10.1016/S0140-6736(19)31288-7. Epub 2019 Jun 13. Erratum in: Lancet. 2019 Jul 27;394(10195):302.

2.

Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi.

Burke HM, Chen M, Buluzi M, Fuchs R, Wevill S, Venkatasubramanian L, Santo LD, Ngwira B.

Glob Health Sci Pract. 2019 Mar 29;7(1):54-65. doi: 10.9745/GHSP-D-18-00433. Print 2019 Mar 22.

3.

Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study.

Kim MK, Seong SJ, Kang SB, Bae DS, Kim JW, Nam JH, Lim MC, Lee TS, Kim S, Paek J.

J Gynecol Oncol. 2019 Mar;30(2):e47. doi: 10.3802/jgo.2019.30.e47. Epub 2019 Jan 7.

4.

A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer.

McKay RR, Werner L, Jacobus SJ, Jones A, Mostaghel EA, Marck BT, Choudhury AD, Pomerantz MM, Sweeney CJ, Slovin SF, Morris MJ, Kantoff PW, Taplin ME.

Cancer. 2019 Feb 15;125(4):524-532. doi: 10.1002/cncr.31836. Epub 2018 Nov 14.

PMID:
30427533
5.

Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women.

Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D.

Menopause. 2018 Nov;25(11):1286-1290. doi: 10.1097/GME.0000000000001230.

PMID:
30358724
6.

Comparison Of Cimicifuga foetida extract and different hormone therapies regarding in causing breast pain in early postmenopausal women.

Wang YP, Ma D, Cheng XT, Zhang SJ, Xue W, Deng Y, Wang YF, Sun AJ.

Gynecol Endocrinol. 2019 Feb;35(2):160-164. doi: 10.1080/09513590.2018.1505845. Epub 2018 Oct 16.

PMID:
30324837
7.

Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.

Kagan R, Abreu P, Andrews E.

Postgrad Med. 2018 Nov;130(8):687-693. doi: 10.1080/00325481.2018.1520046. Epub 2018 Oct 3.

PMID:
30280946
8.

Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.

Zalenskaya IA, Chandra N, Yousefieh N, Fang X, Adedipe OE, Jackson SS, Anderson SM, Mauck CK, Schwartz JL, Thurman AR, Doncel GF.

J Clin Invest. 2018 Oct 1;128(10):4622-4638. doi: 10.1172/JCI120583. Epub 2018 Sep 17.

9.

Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate Users.

Thurman AR, Schwartz JL, Brache V, Chen BA, Chandra N, Kashuba ADM, Weiner DH, Mauck C, Doncel GF.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):79-88. doi: 10.1097/QAI.0000000000001864.

PMID:
30212395
11.

Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial.

Vajaranant TS, Ray RM, Pasquale LR, Mares JA, Ritch R, Gower EW, Haan MN, Jackson RD, Maki PM.

Am J Ophthalmol. 2018 Nov;195:110-120. doi: 10.1016/j.ajo.2018.07.035. Epub 2018 Aug 4.

PMID:
30081016
12.

While women await surgery for type I endometrial cancer, depot medroxyprogesterone acetate reduces tumor glandular cellularity.

Fiascone S, Danilack VA, Kao MJ, Cohen M, Singh K, Kalife E, Luis C, Lokich E, DiSilvestro P, Robison K.

Am J Obstet Gynecol. 2018 Oct;219(4):381.e1-381.e10. doi: 10.1016/j.ajog.2018.07.024. Epub 2018 Jul 29.

PMID:
30063901
13.

Efficacy Of 17- Α-Hydroxy-Progestrone In Prevention Of Preterm Labour In High Risk Pregnant Women.

Shadab W, Riaz S, Aftab F, Shah FH.

J Ayub Med Coll Abbottabad. 2018 Apr-Jun;30(2):209-212.

14.

Slow-wave sleep and androgens: selective slow-wave sleep suppression affects testosterone and 17α-hydroxyprogesterone secretion.

Ukraintseva YV, Liaukovich KM, Polishchuk АA, Martynova ОV, Belov DA, Simenel ES, Meira E Cruz М, Nizhnik АN.

Sleep Med. 2018 Aug;48:117-126. doi: 10.1016/j.sleep.2018.04.012. Epub 2018 May 12.

PMID:
29894840
15.

Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial.

Burke HM, Chen M, Buluzi M, Fuchs R, Wevill S, Venkatasubramanian L, Dal Santo L, Ngwira B.

Contraception. 2018 Nov;98(5):418-422. doi: 10.1016/j.contraception.2018.04.018. Epub 2018 Jun 8.

16.

Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.

Chinula L, Nelson JAE, Wiener J, Tang JH, Hurst S, Tegha G, Msika A, Ellington S, Hosseinipour MC, Mataya R, Haddad LB, Kourtis AP.

Contraception. 2018 Sep;98(3):193-198. doi: 10.1016/j.contraception.2018.05.001. Epub 2018 May 8.

17.

Insulin Regulates Glycogen Synthesis in Human Endometrial Glands Through Increased GYS2.

Flannery CA, Choe GH, Cooke KM, Fleming AG, Radford CC, Kodaman PH, Jurczak MJ, Kibbey RG, Taylor HS.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2843-2850. doi: 10.1210/jc.2017-01759.

18.

A single preovulatory administration of ulipristal acetate affects the decidualization process of the human endometrium during the receptive period of the menstrual cycle.

Lira-Albarrán S, Durand M, Barrera D, Vega C, Becerra RG, Díaz L, García-Quiroz J, Rangel C, Larrea F.

Mol Cell Endocrinol. 2018 Nov 15;476:70-78. doi: 10.1016/j.mce.2018.04.010. Epub 2018 Apr 27.

PMID:
29709683
19.

Multiples of Median-Transformed, Normalized Reference Ranges of Steroid Profiling Data Independent of Age, Sex, and Units.

Zalas D, Reinehr T, Niedziela M, Borzikowsky C, Flader M, Simic-Schleicher G, Akkurt HI, Heger S, Hornig N, Holterhus PM, Kulle AE.

Horm Res Paediatr. 2018;89(4):255-264. doi: 10.1159/000488028. Epub 2018 Apr 25.

PMID:
29694956
20.

A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.

Shambhavi S, Bagga R, Bansal P, Kalra J, Kumar P.

J Obstet Gynaecol. 2018 Aug;38(6):800-806. doi: 10.1080/01443615.2018.1425380. Epub 2018 Mar 20.

PMID:
29557230

Supplemental Content

Loading ...
Support Center